Oncologix Tech, Inc.
OCLG
$0.0001
$0.000.00%
OTC PK
| 05/31/2016 | 05/31/2015 | ||||
|---|---|---|---|---|---|
| Revenue | -34.19% | 25.02% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -34.19% | 25.02% | |||
| Cost of Revenue | -37.42% | 12.27% | |||
| Gross Profit | -26.02% | 75.40% | |||
| SG&A Expenses | -21.18% | 60.25% | |||
| Depreciation & Amortization | -18.00% | -12.28% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -31.94% | 24.56% | |||
| Operating Income | 3.84% | -19.16% | |||
| Income Before Tax | 49.70% | -119.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 49.70% | -119.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 49.70% | -119.83% | |||
| EBIT | 3.84% | -19.16% | |||
| EBITDA | 3.09% | -21.35% | |||
| EPS Basic | 81.82% | -4.76% | |||
| Normalized Basic EPS | 85.71% | -40.00% | |||
| EPS Diluted | 81.82% | -4.76% | |||
| Normalized Diluted EPS | 85.71% | -40.00% | |||
| Average Basic Shares Outstanding | 203.65% | 116.12% | |||
| Average Diluted Shares Outstanding | 203.65% | 116.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||